tadalafil has been researched along with Disease Exacerbation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, D; Dieye, I; Goemans, N; Hossain, I; Jenkins, M; Landry, J; Sajeev, G; Signorovitch, J; Van den Hauwe, M; Ward, SJ; Wong, B; Yao, Z | 1 |
| McClain, SA; Singer, AJ; Towery, H | 1 |
| Barberá, JA; Blair, C; Frost, AE; Galiè, N; Ghofrani, HA; Hoeper, MM; Langley, J; McLaughlin, VV; Miller, KL; Peacock, AJ; Rubin, LJ; Simonneau, G; Vachiéry, JL | 1 |
| Baloira Villar, A; Núñez Fernández, M; Pousada Fernández, G; Valverde Pérez, D | 1 |
| Barberà, JA; Blair, C; Frost, AE; Galiè, N; Ghofrani, HA; Gillies, H; Grünig, E; Harris, JH; Hoeper, MM; Langley, J; McLaughlin, VV; Miller, KL; Oudiz, RJ; Peacock, AJ; Rubin, LJ; Simonneau, G; Vachiery, JL; Vonk-Noordegraaf, A; White, RJ | 1 |
| Barberà, JA; Blair, C; Coghlan, JG; Frost, AE; Galiè, N; Ghofrani, HA; Gillies, H; Harris, JHN; Hoeper, MM; Kuwana, M; Langley, J; McLaughlin, VV; Miller, KL; Peacock, AJ; Rubin, LJ; Simonneau, G; Vachiéry, JL | 1 |
| Beardsworth, A; Fujita, K; Kato, M; Nakazawa, T; Sawamura, F | 1 |
| Helfand, BT; Mazur, DJ; McVary, KT | 1 |
| Calderbank, M; Ivy, DD; Takatsuki, S | 1 |
| Aversa, A; Bruzziches, R; Letizia, C; Menghi, G; Merla, A; Proietti, M; Rossi, C; Salsano, F; Spera, G | 1 |
1 review(s) available for tadalafil and Disease Exacerbation
| Article | Year |
|---|---|
Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Carbolines; Disease Progression; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Men's Health; Middle Aged; Neurotransmitter Agents; Piperazines; Prognosis; Prostatic Hyperplasia; Purines; Receptors, Neurotransmitter; Risk Assessment; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2012 |
5 trial(s) available for tadalafil and Disease Exacerbation
| Article | Year |
|---|---|
Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration.
Topics: Adolescent; Child; Computer Simulation; Disease Progression; Exercise Test; Follow-Up Studies; Humans; Male; Muscular Dystrophy, Duchenne; Neuromuscular Agents; Prognosis; Sample Size; Tadalafil; Walking | 2020 |
Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.
Topics: Aged; Antihypertensive Agents; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Middle Aged; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Pulmonary Arterial Hypertension; Pulmonary Wedge Pressure; Pyridazines; Tadalafil; Treatment Outcome | 2019 |
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Topics: Adult; Aged; Carbolines; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Hypertension, Pulmonary; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenylpropionates; Pyridazines; Risk Factors; Tadalafil | 2015 |
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Topics: Adult; Aged; Antihypertensive Agents; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Male; Middle Aged; Mixed Connective Tissue Disease; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Pyridazines; Scleroderma, Systemic; Tadalafil | 2017 |
Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels.
Topics: Adult; Carbolines; Disease Progression; Endothelin-1; Erectile Dysfunction; Health Surveys; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Scleroderma, Systemic; Tadalafil | 2007 |
4 other study(ies) available for tadalafil and Disease Exacerbation
| Article | Year |
|---|---|
Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Burns; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Ischemia; Naproxen; Necrosis; Random Allocation; Rats; Rats, Sprague-Dawley; Skin; Tadalafil; Vasodilator Agents | 2018 |
Clinical and molecular study of 4 cases of pulmonary hypertension associated with sarcoidosis.
Topics: Bone Morphogenetic Protein Receptors, Type II; Bosentan; Disease Progression; Epoprostenol; Fatal Outcome; Female; Humans; Hypertension, Pulmonary; Kv1.5 Potassium Channel; Male; Middle Aged; Mutation; Phenylpropionates; Point Mutation; Pyridazines; Respiratory Function Tests; RNA, Messenger; Sarcoidosis; Sildenafil Citrate; Sulfonamides; Tadalafil; Treatment Outcome | 2015 |
Tadalafil, a long-acting inhibitor of PDE5, improves pulmonary hemodynamics and survival rate of monocrotaline-induced pulmonary artery hypertension in rats.
Topics: Animals; Blood Gas Analysis; Carbolines; Cyclic GMP; Disease Progression; Dose-Response Relationship, Drug; Hemodynamics; Hydrogen-Ion Concentration; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Organ Size; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Poisons; Pulmonary Circulation; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Survival; Tadalafil | 2009 |
Initial experience with tadalafil in pediatric pulmonary arterial hypertension.
Topics: Adolescent; Carbolines; Cardiac Output; Child; Child, Preschool; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension, Pulmonary; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Retrospective Studies; Sildenafil Citrate; Statistics, Nonparametric; Sulfones; Tadalafil; Treatment Outcome; Vascular Resistance | 2012 |